头孢菌素皮试及其法律问题探讨  

Discussion on Cephalosporin Skin Test and its Legal Issues

作　　者：东振彩[1] 陈蕾伊[2] DONG Zhen-cai;CHEN Lei-yi(Tianjin Children's Hospital;Tianjin Central Hospital of Gynecology Obstetrics)

机构地区：[1]天津市儿童医院 [2]天津市中心妇产科医院

出　　处：《医院管理论坛》2020年第8期14-16,32,共4页Hospital Management Forum

基　　金：天津市医院协会课题,编号:2017008。

摘　　要：头孢菌素输注前是否需要皮试一直是业内争论的焦点问题,特别是没有为患者进行皮试而导致的死亡事件,令很多医护人员望而生畏。本文从多个国家是否进行头孢菌素皮试的现状进行探讨,阐述了各医疗机构进行头孢菌素皮试过程中存在的问题以及由此引发的医疗纠纷,并对头孢菌素皮试的可行性进行探讨,以期为尽快停止头孢菌素皮试提供理论依据。Whether the skin test is required before cephalosporin infusion has always been a focus of debate in the industry.In particular,the deaths caused by the absence of skin tests for patients have made many medical staff daunted.This article discussed the current status of whether cephalosporin skin tests were conducted in many countries,expounded the problems existing in the process of cephalosporin skin tests in various medical institutions and the medical disputes caused by them,and discussed the feasibility of cephalosporin skin tests.It is expected to provide a theoretical basis for stopping the cephalosporin skin test as soon as possible.

关 键 词：头孢菌素 皮试 过敏 

分 类 号：R055[医药卫生]